ATP7B and neoplasm: The drugs act via several mechanisms including the tumor-specific suppression of ATP7B expression and trafficking and the downregulation of large cohorts of genes that belong to cisplatin-resistance pathways including DNA repair, protein quality control, and autophagy [18,19,20,21].